This one's interesting, despite the TGA not being so quick to move on MDMA and similar therapies, it is a different story in the US and I did see something from PyschoGenics last week about its collaboration with Emyria. The understanding I have is that MDMA like doses last 4-6hrs meaning patients being treated don't just undergo psychotherapy, they also need to be monitored in clinic whilst under the dose. So I interpret the metabolic half life studies to mean they refine the 4-6hrs down to avoid day therapies or overnight stays whilst it wears off.
Exciting times for Emyria. There is no bigger stage than the US for this market.
EMD Price at posting:
21.5¢ Sentiment: Buy Disclosure: Held
